Furthermore, upon tamoxifen-induced Kras (G12D) mutation (Lgr5-2A-CreER-T2tg/tg/LSL-Kras(G12D)tg/+), these cells directly progressed to gastric cancer. The gene discussed is KRAS; the disease is gastric cancer.